Compare JRSH & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JRSH | INCR |
|---|---|---|
| Founded | 2016 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 47.4M |
| IPO Year | 2017 | 2021 |
| Metric | JRSH | INCR |
|---|---|---|
| Price | $3.32 | $0.82 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 134.6K | 36.8K |
| Earning Date | 02-09-2026 | 05-01-2026 |
| Dividend Yield | ★ 5.68% | N/A |
| EPS Growth | ★ 56.25 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | ★ $145,812,006.00 | N/A |
| Revenue This Year | $11.64 | $69.54 |
| Revenue Next Year | $10.06 | $41.75 |
| P/E Ratio | $22.00 | ★ N/A |
| Revenue Growth | ★ 24.43 | N/A |
| 52 Week Low | $2.85 | $0.68 |
| 52 Week High | $3.60 | $1.77 |
| Indicator | JRSH | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 48.87 | 49.23 |
| Support Level | $3.20 | $0.72 |
| Resistance Level | $3.47 | $0.91 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 23.68 | 31.25 |
Jerash Holdings (US) Inc along with its subsidiaries, is a manufacturer and exporter of customized, ready-made sport and outerwear from knitted fabric from its production facilities in Jordan. The company manufactures for retailers, including Walmart, Costco, Sears, Hanes, Columbia, Land's End, VF Corporation, and Philip-Van Heusen, which owns brands such as The North Face, Nautica, Timberland, Wrangler, Lee, Jansport, Calvin Klein, Tommy Hilfiger, IZOD, and Speedo. It derives its revenue from the manufacturing and sales of outerwear in the United States. The company's product offering consists of jackets, polo shirts, crew neck shirts, pants, and shorts made from knitted fabric. Geographically, the company generates maximum revenue from the United States.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.